Interaction-based discovery of functionally important genes in cancers
暂无分享,去创建一个
[1] G. Mills,et al. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer , 2012, Genome research.
[2] B. Peters,et al. Distinguishing cancer-associated missense mutations from common polymorphisms. , 2007, Cancer research.
[3] J. Carpten,et al. Clonal competition with alternating dominance in multiple myeloma. , 2012, Blood.
[4] J. Harper,et al. Structure of a -TrCP1-Skp1--Catenin Complex: Destruction Motif Binding and Lysine Specificity , 2003 .
[5] Maria Deak,et al. High-Resolution Structure of the Pleckstrin Homology Domain of Protein Kinase B/Akt Bound to Phosphatidylinositol (3,4,5)-Trisphosphate , 2002, Current Biology.
[6] T. Golub,et al. Impaired microRNA processing enhances cellular transformation and tumorigenesis , 2007, Nature Genetics.
[7] Mona Singh,et al. Disentangling function from topology to infer the network properties of disease genes , 2013, BMC Systems Biology.
[8] Gary D Bader,et al. Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers , 2013 .
[9] Jose M. Duarte,et al. The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors , 2011, Molecular Cancer.
[10] Andrea Ciliberto,et al. Low duplicability and network fragility of cancer genes. , 2008, Trends in genetics : TIG.
[11] Yoshitaka Narita,et al. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. , 2010, Genes & development.
[12] F. Ferrari,et al. A MicroRNA Targeting Dicer for Metastasis Control , 2010, Cell.
[13] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[14] B. Samuelsson,et al. Ribonuclease activity and RNA binding of recombinant human Dicer , 2002, The EMBO journal.
[15] E. Lander,et al. Lessons from the Cancer Genome , 2013, Cell.
[16] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[17] A. Sivachenko,et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer , 2012, Nature Genetics.
[18] Elias Campo Guerri,et al. International network of cancer genome projects , 2010 .
[19] David Haussler,et al. PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis , 2012, Bioinform..
[20] D. Higgins,et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.
[21] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[22] A. Ben-Ze'ev,et al. beta-Catenin signaling in biological control and cancer. , 2007, Journal of cellular biochemistry.
[23] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[24] M. Nakao,et al. Methylation-Mediated Transcriptional Silencing in Euchromatin by Methyl-CpG Binding Protein MBD1 Isoforms , 1999, Molecular and Cellular Biology.
[25] Yan Cui,et al. Prediction of the phenotypic effects of non-synonymous single nucleotide polymorphisms using structural and evolutionary information , 2005, Bioinform..
[26] Koji Nagata,et al. Homodimeric structure and double-stranded RNA cleavage activity of the C-terminal RNase III domain of human dicer. , 2007, Journal of molecular biology.
[27] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[28] A. Gonzalez-Perez,et al. Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation , 2012, Genome Medicine.
[29] Yang Zhang,et al. BioLiP: a semi-manually curated database for biologically relevant ligand–protein interactions , 2012, Nucleic Acids Res..
[30] Spyro Mousses,et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer , 2007, Nature.
[31] Bonnie Berger,et al. iWRAP: An interface threading approach with application to prediction of cancer-related protein-protein interactions. , 2010, Journal of molecular biology.
[32] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[33] Leyla Isik,et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. , 2009, Cancer research.
[34] Paul A. Bates,et al. Global topological features of cancer proteins in the human interactome , 2006, Bioinform..
[35] P. Morin,et al. β‐catenin signaling and cancer , 1999 .
[36] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[37] David Haussler,et al. LS-SNP: large-scale annotation of coding non-synonymous SNPs based on multiple information sources , 2005, Bioinform..
[38] H. Do,et al. Rarity of AKT1 and AKT3 E17K mutations in squamous cell carcinoma of lung , 2010, Cell cycle.
[39] H. Ohtsuki,et al. Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.
[40] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[41] Dong-Yeon Cho,et al. Dissecting cancer heterogeneity with a probabilistic genotype-phenotype model , 2013, RECOMB.
[42] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[43] Frances M. G. Pearl,et al. MoKCa database—mutations of kinases in cancer , 2008, Nucleic Acids Res..
[44] D. Huntsman,et al. Cancer‐associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse‐strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage , 2013, The Journal of pathology.
[45] J. Hopper,et al. Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study , 2011, Breast Cancer Research.
[46] Geng Wu,et al. Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. , 2003, Molecular cell.
[47] Brian H. Dunford-Shore,et al. Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.
[48] M. Guyer,et al. Charting a course for genomic medicine from base pairs to bedside , 2011, Nature.
[49] Eli Upfal,et al. De Novo Discovery of Mutated Driver Pathways in Cancer , 2011, RECOMB.
[50] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[51] R. Altman,et al. A new disease-specific machine learning approach for the prediction of cancer-causing missense variants. , 2011, Genomics.
[52] M. Stratton,et al. The cancer genome , 2009, Nature.
[53] R. Pearson,et al. A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition. , 2006, Cancer research.
[54] Y. Xiong,et al. HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin. , 1999, Oncogene.
[55] S. Sommer. The importance of immune gene variability (MHC) in evolutionary ecology and conservation , 2005, Frontiers in Zoology.
[56] Tom R. Gaunt,et al. Predicting the functional consequences of cancer-associated amino acid substitutions , 2013, Bioinform..
[57] Geng Wu,et al. Structure of a -TrCP1-Skp1--Catenin Complex , 2003 .
[58] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[59] Yu Liu,et al. Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseases , 2012, BMC Systems Biology.
[60] Predrag Radivojac,et al. Gain and Loss of Phosphorylation Sites in Human Cancer , 2022 .
[61] Benjamin A. Shoemaker,et al. Cancer Missense Mutations Alter Binding Properties of Proteins and Their Interaction Networks , 2013, PloS one.
[62] Richard Simon,et al. Identifying cancer driver genes in tumor genome sequencing studies , 2011, Bioinform..
[63] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[64] Thomas A. Peterson,et al. Domain landscapes of somatic mutations in cancer. , 2013, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.
[65] J. Moult,et al. Identification and analysis of deleterious human SNPs. , 2006, Journal of molecular biology.
[66] Hoyun Lee,et al. The Akt isoforms are present at distinct subcellular locations. , 2010, American journal of physiology. Cell physiology.
[67] Ozlem Keskin,et al. Human Cancer Protein-Protein Interaction Network: A Structural Perspective , 2009, PLoS Comput. Biol..
[68] C. Sander,et al. Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.
[69] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[70] M. Kimmel,et al. Conflict of interest statement. None declared. , 2010 .
[71] P. Polakis. Wnt signaling and cancer. , 2000, Genes & development.